Sanofi-Aventis/Zentiva (Commission of the European Communities, Case No COMP/M.5253, February 2009)

Case Description

In early 2009, the Commission of the European Communities cleared the proposed acquisition of the generic drug maker Zentiva N.V. by Sanofi-Aventis Europe, subject to conditions. In light of Sanofi-Aventis’ commitment to divest fifteen drugs in Eastern Europe, the Commission concluded that the proposed acquisition would not harm competition in the internal market.

Decision Year